Moreover, miR-214 in CAFs was reported to be downregulated in patients with ovarian cancer and in addition, the expression of the pro-tumorgenetic chemokine CCL5 was enhanced, finally promoting the invasion and growth of ovarian cancer cells (85). The gene discussed is CCL5; the disease is ovarian carcinoma.